Risk factors
MAIA Biotechnology (MAIA) risk factors
Item 1A of every MAIA Biotechnology, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors79 risks16 new29 dropped27 reworded
MAIA added significant risk disclosures regarding its new corporate treasury policy of acquiring and staking digital assets like Solana.
Filed Mar 23, 2026 - FY2024 10-K risk factors92 risks
MAIA Biotechnology is a clinical-stage biopharmaceutical company dependent on the success of its lead cancer candidate, THIO.
Filed Mar 21, 2025